FDA Adverse Event Injury Summary report: N

SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM

MDR report key: 22910115 · Received August 27, 2025

Report

Report Number
3005875675-2025-00019
Event Type
Injury
Date Received
August 27, 2025
Date of Event
January 18, 2023
Report Date
August 27, 2025
Manufacturer
GYNESONICS
Product Code
KNF
UDI-DI
10817929020326
PMA / PMN Number
K222304
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE WAS NO REPORT OF DEVICE MALFUNCTION DURING THE PROCEDURE AND THE SYSTEM FUNCTIONED AS EXPECTED. SUBMISSION OF THIS REPORT IS ASSOCIATED WITH THE RECENT ACQUISITION OF GYNESONICS BY HOLOGIC, INC. DURING THE INTEGRATION INTO HOLOGIC'S ADVERSE EVENT REPORTING SYSTEM AND PROCEDURES, A REVIEW OF HISTORICAL ADVERSE EVENTS WAS PERFORMED. AS A RESULT, THIS EVENT WAS IDENTIFIED AS BEING REPORTABLE ON (B)(6) 2025 AND IS BEING REPORTED RETROACTIVELY OUT OF AN ABUNDANCE OF CAUTION.

Description of Event or Problem · 0

45YO WITH VERY LARGE FIBROID BURDEN (>20 FIBROIDS). SONATA PERFORMED WITH 8 ABLATIONS TO COVER THE LARGEST FIBROID REGIONS. NO ISSUES DURING THE PROCEDURE. CALLED ON POD2 WITH FEVERS TO 101.5, NAUSEA, MALAISE, AND INCREASED PAIN. REQUIRING OXYCODONE, IBUPROFEN, AND TYLENOL. - PROPHYLACTIC ANTIBIOTICS GIVEN DURING SURGERY - GIVEN DOXYCYCLINE WHEN SHE CALLED AND SAYS THAT HER SYMPTOMS WERE IMPROVING 3 DAYS AFTER STARTING THE ANTIBIOTICS ".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1834413 SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM KNF GYNESONICS SONATA2-110 10817929020326

Patients

Seq Age Sex Outcome Treatment
1 45 YR Female Required Intervention